Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 April - 4 May 2024 and includes updates on cholera, MERS-CoV, SARS-CoV-2, an overview of respiratory virus epidemiology in the EU/EEA, highly pathogenic avian influenza A(H5N1) in cattle and a related human case, Crimean-Congo haemorrhagic fever, and Lassa fever.
Arenaviruses are a type of small virus commonly found in rodents. When a person becomes infected with an arenavirus, symptoms usually begin within 10 days.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 May 2023 and includes updates on measles, COVID-19, influenza and swine influenza, group A Streptococcal infection, Marburg virus disease, Lassa fever, diphtheria and mpox.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 February 2022, and includes updates on COVID-19, Influenza, polio, cholera, Lassa fever, and mass gathering monitoring for the Winter Olympic Games in Beijing.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 February 2022, and includes updates on COVID-19, Influenza, Lassa fever, mass gathering monitoring for the Winter Olympic Games in Beijing, Chikungunya, and dengue.
For 2019, two imported cases of Lassa fever were reported in the Netherlands. No further cases of Lassa fever or other viral haemorrhagic fevers caused by arenaviruses were reported in the EU/EEA in 2019.